Segments - Throat Lozenges Market by Product Type (Compressed Lozenges, Hard Candy Lozenges, Soft Lozenges, and Chewable Lozenges), Indication (Oral Thrush, Sore Throat, Cough and Cold, and Others), Distribution Channel (Pharmacy, Online Pharmacy, and Others), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2031
The global throat lozenges market was valued at USD 5,330.7 Mn in 2022 and is anticipated to reach USD 8,325.6 Mn by 2031, expanding at a CAGR of 5.3% during the forecast period.
Throat lozenges known as cough drops or troches, are small medicated tablets that dissolve slowly in the mouth. They are consumed to get relief from dryness, irritation, or inflammation in the throat caused by common colds, flu, allergies, or even by prolonged talking or singing. Throat lozenges often contain soothing ingredients, such as menthol, eucalyptus oil, or honey, to help ease discomfort.
Some variants contain mild analgesics and antiseptics to combat sore throat pain and infection. Lozenges are flavored medicated dosage formulations that are sucked and kept in the mouth or pharynx. Usually in a sweetening base, they contain one or more medicinal products.
The benefit of medicated lozenges is that they improve the retention period in the mouth of the medicinal product type, increase bioavailability, reduce stomach discomfort, and bypass the metabolism of the first pass. Overuse of throat lozenges is not recommended and the directions of use are required to be followed carefully.
Increasing number of HIV patients is expected to impact the market. People infected with HIV often experience flu-like illness and the most common symptoms are raised temperature (fever) and sore throat. For instance, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS), an estimated 39 million people were living with HIV in 2022, up from 31.5 million in 2010.
The rising geriatric population across the globe is expected to impact the throat lozenge market in the coming years. The old age population always remains at a high risk of infections, owing to their low immunity. Cough or sore throat is the most common type of infection that appears in the geriatric population. However, throat lozenges provide temporary relief from these symptoms. For instance, according to research released by the World Health Organization (WHO), the number of individuals aged 60 years and above is expected to rise from 12% to 22% between 2015 and 2050 across the globe.
Rising strep infection rates among children are expected to drive the market, as it is more common in children than adults. For instance, according to a report by Epic Research, strep throat infections have increased in the last six years, and it has maintained abnormally high levels as compared to pre-pandemic rates. The research found that strep cases increased by 30% in April 2023 than it was in February 2017.
The common cold is a minor infection of the nose and throat, which is caused by more than 200 different viruses, including Rhinovirus. For instance, according to the American Lung Association, adults get an average of two to four colds per year and young children suffer an average of six to eight colds per year. In addition, cold accounts for more doctor visits than any other condition in the US.
However, common cold symptoms include sore throat or scratchy throat, which require throat lozenges to get relief. This, in turn, is expected to boost the throat lozenges market in the coming year.
Lack of awareness about the effectiveness of medicated throat lozenges in developing economies restrains the market. The presence of counterfeit products in the market potentially affects on the brand image and profitability of trusted throat lozenge manufacturers. Furthermore, the increasing trend towards natural and organic products hampers the market, as people started preferring natural remedies over manufactured lozenges.
The growing consumer awareness about the benefits of using throat lozenges, such as soothing the throat, reducing irritation and coughing, killing bacteria, and boosting immunity is expected to create an immense opportunity for the key players.
Additionally, an increasing preference for natural and herbal ingredients, such as pectin, zinc gluconate, menthol, eucalyptus oil, honey, lemon, ginger, and turmeric, which are perceived to be safer and more effective than synthetic or chemical-based products is expected to create an opportunity in the coming year.
The report on the global throat lozenges market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Throat Lozenges Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Product Type (Compressed Lozenges, Hard Candy Lozenges, Soft Lozenges, and Chewable Lozenges), Indication (Oral Thrush, Sore Throat, Cough and Cold, and Others), Distribution Channel (Pharmacy, Online Pharmacy, and Others) |
Regional Scope |
Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered |
Bliss GVS Pharma Ltd., Cipla Health Ltd., GSK, iHerb, LLC., Nestlé, Prestige Consumer Healthcare Inc., Procter & Gamble, Reckitt Benckiser Group PLC., Sanofi S.A, and Walgreen Co. |
Based on product type, the global throat lozenges market is segmented into compressed lozenges, hard candy lozenges, soft lozenges, and chewable lozenges. The hard candy lozenges segment dominated the market in 2022, owing to its availability in different sizes, forms, and flavors, which makes them popular among individuals of all age groups. Moreover, the compressed lozenges segment is projected to grow at a significant pace, due to their long breakdown time and shelf life.
Based on indication, the global throat lozenges market is segmented into oral thrush, sore throat, cough and cold, and others. The cough and cold segment are expected to grow gradually as a contagious feature of cough and cold, combined with a rise in common cold symptoms, is expected to drive the segment in the coming year.
Based on distribution channel, the global throat lozenges market is segmented into pharmacy, online pharmacy, and others. The pharmacy segment is projected to expand at a considerable CAGR during the forecast period, owing to the rising consumer engagement through retail pharmacy services.
On the basis of region, the global throat lozenges market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa (MEA). North America is expected to hold a significant share of the market during the forecast period, owing to the rising aging and elderly population.
Moreover, high prevalence of respiratory conditions, such as coughs, colds, and allergies, in the region is contribute to the growth of the market. These conditions require constant need for throat lozenges as an over-the-counter product. For instance, according to a report published by the National Library of Medicine in 2023, Europe and North America has a high prevalence of chronic cough than in Asia Pacific.
In-depth Analysis of the Global Throat Lozenges Market
Historical, Current, and Projected Market Size in Terms of Value
Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
Industry Drivers, Restraints, and Opportunities Covered in the Study
Recent Industry Trends and Developments
Competitive Landscape & Strategies of Key Players
Key players operating in the global throat lozenges market include Bliss GVS Pharma Ltd., Cipla Health Ltd., GSK, iHerb, LLC., Nestlé, Prestige Consumer Healthcare Inc., Procter & Gamble, Reckitt Benckiser Group PLC., Sanofi S.A, and Walgreen Co.
Market players are pursuing strategies, such as acquisitions, product launches, collaborations, and geographic expansion, to leverage untapped opportunities in the global throat lozenges market.
In January 2021, Moberg Pharma, a Sweden-based Pharmaceutical Company, and its subsidiary OncoZenge AB announced that the European Patent Office (EPO) has granted patent 3 284 459, which protects BupiZenge, currently in development for the treatment of pain, due to oral mucositis. The patent is expected to be in effect in 2032.
In March 2020, Uncle Joe's Mint Balls, a US-based sweet confectionery company, switched its manufacturing to Throat & Lung and Herbal Cough lozenges.
Additional company profiles can be provided on request. For a discussion related to the above findings, click Speak to Analyst
Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.
The rise in strep infection rates and frequent occurrence of the common cold are expected to drive the market growth during the forecast period.
According to this Growth Market Reports report, the global throat lozenges market is anticipated to register a CAGR of 5.3% during the forecast period 2023-2031, with a projected valuation of USD 8,325.6 million by the end of 2031.
Factors such as the increasing number of HIV patients and the rising geriatric population are analyzed in the final report.
Major players operating in the market include Bliss GVS Pharma Ltd., Cipla Health Ltd., GSK, iHerb, LLC., Nestlé, Prestige Consumer Healthcare Inc., Procter & Gamble, Reckitt Benckiser Group PLC., Sanofi S.A, and Walgreen Co.
The outbreak of coronavirus disease in 2019 (COVID-19) hampered the global throat lozenges market. The impact of COVID-19 on throat lozenges market was widespread, ranging from workforce and staffing issues to procedural prioritization and viral transmission risk intraoperatively.
Lack of awareness about the effectiveness of medicated throat lozenges is expected to hinder the market.
The forecast year considered for the global throat lozenges market report is 2031.
The base year considered for the global throat lozenges market report is 2022. The complete analysis period is 2016 to 2031, wherein, 2016 to 2021 are the historic years, and the forecast is provided from 2023 to 2031.